April 30, 2020
Off
Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis
By BusinessWireBAFIERTAM™ (monomethyl fumarate), the bioequivalent alternative to Biogen’s Tecfidera® (dimethyl fumarate), is a new oral treatment option for relapsing forms…